Naoe Yamane

Identification of the Rate-Determining Process in the Hepatic Clearance of Atorvastatin in a Clinical Cassette Microdosing Study

Kazuya Maeda, Yasumasa Ikeda, Tomoe Fujita et al. · Clinical Pharmacology & Therapeutics · 2011 · 207 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Microdose clinical trial: Quantitative determination of fexofenadine in human plasma using liquid chromatography/electrospray ionization tandem mass spectrometry

Naoe Yamane, Zenzaburou Tozuka, Yuichi Sugiyama et al. · Journal of Chromatography B · 2007 · 75 citations

Pharmacy, Pharmacology, Toxicology +16

Fully validated LCMS bioanalysis of Bevacizumab in human plasma using nano-surface and molecular-orientation limited (nSMOL) proteolysis

Noriko Iwamoto, Yukari Umino, Chikage Aoki et al. · Drug Metabolism and Pharmacokinetics · 2015 · 51 citations

Pharmacy, Medicinal Chemistry, Pharmaceutical Analysis +11

Mechanisms of Pharmacokinetic Enhancement Between Ritonavir and Saquinavir; Micro/Small Dosing Tests Using Midazolam (CYP3A4), Fexofenadine (p‐Glycoprotein), and Pravastatin (OATP1B1) as Probe Drugs

Ichiro Ieiri, Shyohei Tsunemitsu, Kazuya Maeda et al. · The Journal of Clinical Pharmacology · 2013 · 33 citations

Medicine, Pharmacokinetics, Pharmacology +8

Microdose study of a P-glycoprotein substrate, fexofenadine, using a non-radioisotope-labelled drug and LC/MS/MS

Akira Yamazaki, Yoshito Kumagai, Naoe Yamane et al. · Journal of Clinical Pharmacy and Therapeutics · 2010 · 32 citations

Pharmacy, Pharmacokinetics, Pharmacology +13